• AFP-JIJI

  • SHARE

COVID-19 vaccines have brought billions of dollars to the coffers of pharmaceutical companies.

Germany’s BioNTech SE, maker with partner Pfizer Inc. of a pioneering messenger RNA (mRNA) shot, raised its vaccine revenue forecast for 2021 in its latest earnings report Monday.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)